Kaletra (Lopinavir 200 mg / Ritonavir 50 mg) — Patient Information (Australia)

Kaletra is a brand of antiviral medicine used to treat HIV (Human Immunodeficiency Virus). It contains two active medicines in each dose: lopinavir 200 mg and ritonavir 50 mg. This combination helps control HIV replication and can reduce the amount of virus in the body.

This page provides detailed, patient-friendly information for people in Australia, including how Kaletra works, typical uses, timing, food and alcohol interactions, safety considerations, and practical tips for daily life.

1. Basic product information

In HIV treatment, Kaletra is usually taken as part of a broader antiretroviral regimen (often with additional HIV medicines). Your healthcare team will determine the best combination for you.

2. How Kaletra works (mechanism of action)

HIV needs enzymes to build new virus particles. One of these enzymes is HIV protease. Lopinavir inhibits HIV protease. This prevents HIV from processing its proteins correctly, which means new viruses produced in your body are less able to infect other cells.

Ritonavir is included in Kaletra at a low dose to “boost” lopinavir levels. Ritonavir slows the breakdown of lopinavir in the liver, allowing lopinavir to stay at effective concentrations longer. This “boosting” improves lopinavir exposure and helps maintain consistent antiviral activity.

3. Pharmacokinetics (how the body handles it)

Pharmacokinetics describes absorption, distribution, metabolism, and elimination of medicines.

• Absorption: Lopinavir/ritonavir is absorbed after oral dosing. Taking it with food can improve consistency of absorption.
• Metabolism: Both components are primarily metabolised in the liver, largely via the CYP3A enzyme system.
• Boosting effect: Ritonavir reduces CYP3A activity, increasing lopinavir concentrations.
• Half-life and steady levels: Because ritonavir boosts lopinavir, blood levels are maintained with regular dosing schedules. Many people take Kaletra multiple times daily depending on their regimen and formulation.
• Elimination: Metabolites are eliminated mainly through bile and faeces, with a smaller proportion via urine.

Individual factors (such as liver function, other medicines, and adherence) can affect drug levels. Your treating clinician may monitor HIV viral load and, when needed, consider additional monitoring for safety.

4. Typical use and indications

Kaletra is used as part of combination antiretroviral therapy (ART) to manage HIV infection. The goals of therapy include:

• Reducing HIV viral load to undetectable or as low as possible
• Increasing and preserving immune function (for example, raising/maintaining CD4 cell counts)
• Preventing disease progression and reducing HIV-related complications
• Reducing the risk of HIV transmission when viral suppression is achieved and maintained

Indications depend on your treatment history, prior HIV medication exposure, drug resistance profile, and overall health. Kaletra may be selected when a protease inhibitor-based approach is appropriate.

5. Dosing: what to expect

Dosage should be individualised by your healthcare clinician based on your HIV regimen, formulation, age, weight considerations (where applicable), liver function, and potential drug–drug interactions. Always follow the dosing schedule provided to you.

Common dosing approach (general guidance)

• Timing and frequency: Kaletra is commonly taken twice daily or as otherwise directed for your specific regimen.
• Consistency: Try to take each dose at roughly the same times each day.
• Do not change dose: Do not stop or adjust without medical advice, even if you feel well.

Missed dose guidance (general)

• If you miss a dose, take it as soon as you remember unless it is close to the time of the next dose.
• If you are near the next scheduled dose, skip the missed dose and continue your normal schedule.
• Do not take a double dose to make up for the missed one.

If you are unsure what to do after a missed dose, contact your healthcare team or pharmacist for advice.

6. Timing with food

Food can affect how much of lopinavir/ritonavir is absorbed. For many people, taking Kaletra with food improves tolerability and may help absorption consistency. Follow the specific directions given for your product and regimen.

• Take with a meal or snack when directed (your prescribing information will specify recommendations).
• If you experience stomach upset, taking with food may reduce symptoms for some people.
• Try to avoid large changes in meal patterns suddenly, because this can affect how consistently you absorb the medicine.

7. Food interactions (what to watch for)

Beyond basic “with food” guidance, consider the following practical points:

• Grapefruit and grapefruit juice: Many protease inhibitor medicines interact with substances that affect CYP enzymes. To reduce the risk of interactions, it is often recommended to avoid grapefruit unless your clinician/pharmacist advises otherwise.
• High-fat meals: Higher-fat meals can influence absorption of some HIV protease inhibitors. If your clinician gives specific meal guidance, follow it.
• General diet consistency: Maintaining a stable diet routine can help steady medication levels.

Always tell your pharmacist about any supplements, herbal products, or “natural” products you take, because these can sometimes interact with antiretrovirals.

8. Alcohol interactions

Alcohol does not always have a direct interaction with every component of Kaletra, but caution is recommended because:

• Kaletra contains ritonavir, which can affect liver metabolism.
• Alcohol can increase the risk of liver irritation and may worsen gastrointestinal side effects (such as nausea or diarrhoea).
• If you have hepatitis B or C co-infection, or pre-existing liver disease, limiting alcohol is particularly important.

If you choose to drink alcohol, discuss safe amounts with your healthcare team. Report symptoms such as upper abdominal pain, unusual tiredness, dark urine, yellowing of the skin/eyes, or persistent nausea.

9. Important medicine interactions

Kaletra can interact with many medicines due to its effect on liver enzymes (particularly CYP3A) and transport proteins. Some interactions can make Kaletra less effective; others can increase the risk of side effects from other medicines.

Key interaction principles

• Many anticonvulsants and some antibiotics/antifungals can significantly alter drug levels.
• Hormonal contraception and some other hormonal therapies may be affected.
• Blood thinners (anticoagulants) may require careful monitoring and dose adjustments.
• Statins (cholesterol-lowering medicines) may require switching or dose changes due to risk of muscle-related side effects.
• Some medicines may be contraindicated or strongly discouraged with Kaletra.

Herbal and “natural” products to avoid or check

• St John’s wort (Hypericum perforatum): commonly causes significant reductions in antiretroviral levels.
• Other herbal products: always check with a pharmacist before use.

Provide your pharmacist with a complete list of all medicines and supplements you take, including: prescription medicines, over-the-counter medicines, vitamins, mineral supplements, and herbal products.

10. Safety profile and possible side effects

Like all medicines, Kaletra can cause side effects. Not everyone will experience them. Many side effects are manageable, and some improve after the first few weeks of therapy.

Common side effects

• Diarrhoea or loose stools
• Nausea or stomach discomfort
• Headache
• Fatigue
• Raised blood lipid levels (cholesterol and triglycerides) in some people

Less common but important adverse effects

• Changes in liver function (higher liver enzymes). Tell your clinician if you have hepatitis or symptoms of liver trouble.
• Rash (seek advice if rash is severe, blistering, or accompanied by fever).
• Pancreatitis (rare, but urgent if severe abdominal pain occurs).
• Cardiac rhythm changes in susceptible people or with certain interacting medicines (QT-related concerns may apply for some drugs).

Immune reconstitution inflammatory syndrome (IRIS)

When starting or changing ART, some people can develop inflammatory responses due to improved immune function. This is not caused by Kaletra alone, but can occur after ART is initiated.

Warning signs—seek urgent medical help

• Severe or persistent abdominal pain (especially if accompanied by vomiting)
• Yellowing of skin/eyes, dark urine, or severe fatigue
• Fainting, severe dizziness, or palpitations
• Signs of a severe allergic reaction (swelling of face/lips, difficulty breathing)

11. Practical use tips (for day-to-day success)

• Use reminders: Set phone alarms or use a pill organiser to reduce missed doses.
• Take with food when advised: If your instructions say “with meals,” try to match your dose with breakfast/dinner or another regular meal.
• Stay consistent: Sudden changes in meal timing or major schedule shifts can affect absorption and tolerability.
• Manage stomach side effects:
  • Consider eating smaller, lighter meals if nausea occurs.
  • Stay hydrated if diarrhoea occurs, and tell your clinician if it is persistent.
• Keep a current medication list: Bring it to appointments and review it whenever you start a new medicine.
• Do not miss clinic monitoring: Viral load and routine blood tests help ensure treatment remains effective and safe.
• Report symptoms early: Early discussion can prevent complications and improve tolerability.

12. Alternatives to Kaletra

HIV treatment is highly individualised. Alternatives to Kaletra (lopinavir/ritonavir) depend on: previous treatment history, resistance testing, drug interactions, pregnancy status, comorbidities, and convenience.

Examples of alternative antiretroviral options (categories)

• Other protease inhibitors (boosted or unboosted), sometimes used in PI-based regimens.
• Integrase inhibitors (often preferred in many modern regimens due to potency and tolerability profiles for many patients).
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs).
• Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) as part of combination therapy.

Your clinician can discuss whether switching is appropriate if you experience side effects, adherence barriers, or drug interactions. Switching therapy should be planned carefully to preserve viral suppression.

13. Market and legal context for Australia

In Australia, medicines including Kaletra are regulated under the Therapeutic Goods Administration (TGA) framework. Availability may be influenced by supply, prescribing practices, and updates to product listings.

HIV medicines are also supported through Australia’s public health system and medication access pathways, depending on eligibility and location. Many people access HIV treatment through specialised clinics and prescribing services.

Product availability can change over time due to manufacturer supply, distribution arrangements, and pharmacy stock levels.

14. Recent guidance and clinical monitoring (general overview)

Clinical guidance for HIV treatment in Australia is informed by international and local recommendations. While specific guidance can change, common themes in recent years include:

• Rapid initiation and maintaining viral suppression: Effective ART should be continued to reduce the risk of disease progression and transmission.
• Individualised regimen choice: Clinicians consider drug interactions, comorbidities, and resistance patterns.
• Monitoring: Routine blood tests are used to assess viral load, CD4 count, liver function, and metabolic effects (e.g., lipids).
• Adherence support: Simplifying regimens or switching to better-tolerated options may improve adherence.

Always rely on your treating clinician for advice relevant to your personal situation and the most current recommendations.

15. Delivery and availability in Australia

Availability of Kaletra can vary by: product form (depending on what is currently supplied), stock levels at the pharmacy, and manufacturer supply.

• Stock checks: Your order may require verification of current supply before dispatch.
• Dispatch time: Delivery schedules depend on location and courier service.
• Cold-chain: Kaletra typically does not require temperature-controlled shipping, but always follow the instructions on the product packaging.

If a particular strength or formulation is not available immediately, a pharmacist may suggest the closest available option or an alternative where appropriate. Availability timelines vary; if you have urgent needs, contact the pharmacy store for the latest information.

16. Storage and handling

• Store below 30°C unless the product packaging states otherwise.
• Keep in the original packaging to protect from moisture.
• Keep out of reach of children.
• Do not use after the expiry date printed on the pack.

If you have questions about how to store your specific Kaletra product, check the box label or ask your pharmacist.

17. FAQ — Kaletra (lopinavir 200 mg / ritonavir 50 mg)

Is Kaletra used to cure HIV?

No. Kaletra is part of ART and helps control HIV. When taken as part of a consistent regimen, it can lead to long-term viral suppression. Stopping or missing doses can allow the virus to rebound.

How quickly does Kaletra work?

Some people see decreases in viral load within weeks, but “undetectable” viral load is assessed over time with blood tests. Your clinician will monitor treatment response.

What should I do if I miss a dose?

Take it as soon as you remember unless the next dose is soon. If the next dose is close, skip the missed dose. Do not take double doses. If unsure, ask your pharmacist.

Can I take Kaletra with meals?

Taking Kaletra with food is commonly recommended to improve absorption and may help stomach side effects. Follow the specific instructions for your product and your regimen.

Are there foods I should avoid?

Grapefruit and grapefruit juice are often avoided with many protease inhibitor-based regimens due to interaction risk. If you are unsure about a specific food or supplement, ask your pharmacist.

Can I drink alcohol while on Kaletra?

Moderate alcohol may be possible for some people, but caution is advised—particularly because of potential liver effects and gastrointestinal side effects. Discuss safe options with your healthcare team, especially if you have liver disease or hepatitis.

What medicines commonly interact with Kaletra?

Many medicines may interact with Kaletra, including some anticonvulsants, antifungals/antibiotics, cholesterol medicines (statins), blood thinners, and certain hormonal medications. Always provide a full list of your medicines and supplements to your pharmacist.

What monitoring might I need?

Typical monitoring includes viral load, CD4 counts, and blood tests for liver function and metabolic parameters such as lipids. Your clinician may adjust monitoring based on your individual risk factors.

What side effects should prompt me to seek medical help?

Seek urgent advice for severe abdominal pain (possible pancreatitis), symptoms of liver problems (yellow skin/eyes, dark urine), signs of serious allergic reaction, or fainting/palpitations.

Are there alternatives if I can’t tolerate Kaletra?

Yes. There are multiple ART options, including other protease inhibitors or different drug classes. Switching should be planned carefully to maintain viral suppression and avoid resistance.

Where can I get Kaletra in Australia?

Kaletra may be available through pharmacies that supply HIV medicines, and access can depend on your treatment pathway and current stock. Delivery times may vary based on availability.

Note: This information is intended to help you understand Kaletra. It does not replace individual medical advice. For guidance tailored to you—especially for dosing, interactions, and side-effect management—speak with your pharmacist or healthcare team.